News

OliX Pharmaceuticals, Inc. , a leading developer of RNA interference (RNAi), announced that it will leverage previous preclinical research for developing siRNA therapeutics in treating respiratory illnesses to investigate a path forward for developing a COVID-19 therapy. COVID-19 belongs to...

The company’s new CDMO, Exothera, has been created to help the cell and gene therapy sector increase its capacity, and also boost its bioprocessing expertise. The CDMO will create bespoke bioproduction support programmes for manufacturers to achieve successful market...

CytomX Therapeutics, Inc and Astellas Pharma Inc. announced they have entered into a strategic collaboration agreement focused on the discovery, research, development and commercialization of novel T-cell engaging bispecific antibodies targeting CD3 and tumor cell surface antigens for the...

The Pharma & Biopharma Outsourcing Association (PBOA), a trade group that represents Contract Manufacturing Organizations (CMOs) and other service providers in the bio/pharmaceutical sector, reports that its member companies remain committed to serving patients by manufacturing effective, quality products...

Alembic Pharmaceuticals on Monday said that US health regulator has conducted an inspection at it Panelav facility in Gujarat and issued Form 483 with four procedural observations. "The US Food and Drug Administration (USFDA) has conducted an inspection at Alembic...

Roche announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2 Test. It is intended for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19 disease, in nasopharyngeal...

Clinerion has gained ISO 27001:2013 certification, the international standard that describes best practice for an information security management system (ISMS). ISO 27001:2013 is a standard set by the International Organization for Standardization (ISO), the independent, non-governmental international organization of national...